Trials / Terminated
TerminatedNCT00122915
CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain
A Prospective, Randomized, Double Blind, Crossover, Multi-center Study to Evaluate the Safety and the Efficacy of Motor Cortex Stimulation With the Cortical Stimulation Lead Model 2976 in Patients With Neuropathic Pain
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The CONCEPT study has been designed to evaluate the safety and the efficacy of Motor Cortex Stimulation (MCS) with a new cortical lead (circular lead, eight electrodes, Medtronic Inc, Minneapolis, USA) in the treatment of intractable neuropathic pain, in particular for central post-stroke pain (CPSP) and trigeminal neuropathic pain (TGN)/facial pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cortical lead, 8 electrodes (Model 2976) with Synergy neurostimulator |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2005-07-22
- Last updated
- 2018-02-23
Locations
11 sites across 4 countries: Austria, Belgium, Germany, Spain
Source: ClinicalTrials.gov record NCT00122915. Inclusion in this directory is not an endorsement.